Agios Pharmaceuticals (AGIO) Cash & Equivalents (2012 - 2026)
Agios Pharmaceuticals' Cash & Equivalents came in at $99.65 million for Q2 2026, up 23.2% from $80.87 million a year earlier but down 12.3% from the prior quarter.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Cash & Equivalents (2012 - 2026) Analysis & Trends
At the end of FY2025, Agios Pharmaceuticals' Cash & Equivalents was $89.13 million, up 16.9% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -6.9% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $76.25 million in FY2024 (-13.6%), $88.21 million in FY2023 (-36.7%), $139.26 million in FY2022 (-31.4%) and $203.13 million in FY2021 (+59.4%).
- The five-year range for quarterly Cash & Equivalents is $64.33 million (Q3 2023) to $400.22 million (Q3 2021).
- Year-over-year, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 32.9% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2024 (growth of 294.4%), and the weakest in Q1 2022 (a decline of 95.8%).
- Business Quant data shows AGIO's Cash & Equivalents at $113.6 million (Q1 2026), $89.13 million (Q4 2025) and $92.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Agios Pharmaceuticals | 1.90 Bn | 1.90 Bn | 41.75 Mn | 99.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.65 Mn |
| Mar 31, 2026 | 113.60 Mn |
| Dec 31, 2025 | 89.13 Mn |
| Sep 30, 2025 | 92.71 Mn |
| Jun 30, 2025 | 80.87 Mn |
| Mar 31, 2025 | 78.96 Mn |
| Dec 31, 2024 | 76.25 Mn |
| Sep 30, 2024 | 253.73 Mn |
| Jun 30, 2024 | 84.52 Mn |
| Mar 31, 2024 | 118.76 Mn |
| Dec 31, 2023 | 88.21 Mn |
| Sep 30, 2023 | 64.33 Mn |
| Jun 30, 2023 | 84.75 Mn |
| Mar 31, 2023 | 104.14 Mn |
| Dec 31, 2022 | 139.26 Mn |
| Sep 30, 2022 | 122.45 Mn |
| Jun 30, 2022 | 88.54 Mn |
| Mar 31, 2022 | 80.03 Mn |
| Dec 31, 2021 | 203.13 Mn |
| Sep 30, 2021 | 400.22 Mn |
API Access
Agios Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AGIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AGIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AGIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();